Genetics play a pivotal role in MH. The ryanodine receptor (RYR1), dihydropyridine (DHP), SH3 and cysteine-rich domain 3 (STAC3) receptors, and the aspartate beta-hydroxylase (ASPH) receptor are all integral players in MH's pathogenesis. Of note, the ASPH receptor is also linked to exertional heat illness, a condition bearing a stark resemblance to MH.
The key step is understanding the patient's personal and blood-relative family history. Adverse reactions linked genetically can have significant implications for anesthetic management. History suggestive of MH or any hypermetabolic state in the perioperative timeframe should be flagged..
Beyond the typical reactions during anesthesia, several subtle signs could point to an individual's susceptibility to MH. Some patients have reported unexplained fevers or muscle cramping in response to physical exertion or infection. These symptoms might be indicative of a unique phenomenon termed "awake MH." This condition mirrors MH, without the exposure to triggering agents, and is believed to be activated by systemic stressors.
Furthermore, several genetic conditions, although rare, heighten the risk of MH. Diseases like central core myopathy, King-Denborough syndrome, and STAC3 myopathy all showcase abnormalities in the ryanodine receptor, a known nexus for MH. Additionally, individuals suffering from particular enzymopathies of skeletal muscles or those who have endured severe exertional rhabdomyolysis are at an elevated risk. This elevated risk is especially pronounced in the context of the "awake MH" phenomenon.
